'I could barely function' – the devastating effects of long COVID
Most people recover from COVID-19 within two weeks; however, early figures show that around 10% of people are still unwell after three weeks, and a smaller proportion are sick for months. (Source: The Pharmaceutical Journal)
Source: The Pharmaceutical Journal - November 5, 2020 Category: Drugs & Pharmacology Source Type: research
Aspirin added to RECOVERY COVID-19 trial, MPs told
Aspirin is the latest drug to be added to the Randomised Evaluation of COVID-19 Therapy trial, the chair of the trial has told MPs. (Source: The Pharmaceutical Journal)
Source: The Pharmaceutical Journal - November 5, 2020 Category: Drugs & Pharmacology Source Type: research
Cefiderocol effective for carbapenem-resistant Gram-negative infections
The clinical and microbiological outcomes of cefiderocol, a new antibiotic, were similar to the best available therapy for patients with life-threatening carbapenem-resistant infections, a phase III study has suggested. (Source: The Pharmaceutical Journal)
Source: The Pharmaceutical Journal - November 5, 2020 Category: Drugs & Pharmacology Source Type: research
Pharmaceutical leech jar, 19th century
This drug jar was used in the 19th century to store leeches, which were used to treat localised swelling and infections. (Source: The Pharmaceutical Journal)
Source: The Pharmaceutical Journal - November 5, 2020 Category: Drugs & Pharmacology Source Type: research
Pharmacy delivery service for shielding patients to restart in England
The pandemic delivery service will be restarting in England following updated advice from the government that people who are “clinically extremely vulnerable” should not go to a pharmacy. (Source: The Pharmaceutical Journal)
Source: The Pharmaceutical Journal - November 4, 2020 Category: Drugs & Pharmacology Source Type: research
